Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers

…, HA Ghofrani, ZC Jing, C Opitz, HJ Seyfarth… - Journal of the American …, 2006 - jacc.org
Objectives : This study sought to assess the risks associated with right heart catheter
procedures in patients with pulmonary hypertension. Background : Right heart catheterization, …

Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo …

…, M Arnrich, L Ilie, A Wald, HJ Seyfarth… - The Lancet …, 2021 - thelancet.com
Background Pirfenidone has been shown to slow disease progression in patients with
idiopathic pulmonary fibrosis (IPF). However, there are few treatment options for progressive …

Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the COMPERA registry

…, A Filusch, M Germann, R Ewert, HJ Seyfarth… - International journal of …, 2013 - Elsevier
Background Originally reported to occur predominantly in younger women, idiopathic pulmonary
arterial hypertension (IPAH) is increasingly diagnosed in elderly patients. We aimed to …

[HTML][HTML] COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertension

…, M Halank, H Wilkens, HJ Seyfarth… - European …, 2022 - Eur Respiratory Soc
Background Risk stratification plays an essential role in the management of patients with
pulmonary arterial hypertension (PAH). The current European guidelines propose a three-…

Combining inhaled iloprost with bosentan in patients with idiopathic pulmonary arterial hypertension

…, H Wilkens, FJ Meyer, HJ Seyfarth… - European …, 2006 - Eur Respiratory Soc
Addition of inhaled iloprost to bosentan may have beneficial effects in patients with idiopathic
pulmonary arterial hypertension (IPAH). A multicentre, open, randomised, controlled trial …

Safety and efficacy of exercise training in various forms of pulmonary hypertension

…, M Halank, C Fischer, HJ Seyfarth… - European …, 2012 - Eur Respiratory Soc
The objective of this prospective study was to assess safety and efficacy of exercise training
in a large cohort of patients with different forms and World Health Organization (WHO) …

Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo …

…, H Wilkens, D Mertens, HJ Seyfarth… - European heart …, 2016 - academic.oup.com
Aims The impact of exercise training on the right heart and pulmonary circulation has not yet
been invasively assessed in patients with pulmonary hypertension (PH) and right heart …

Bosentan therapy for portopulmonary hypertension

…, C Marx, G Hoeffken, HJ Seyfarth… - European …, 2005 - Eur Respiratory Soc
The dual endothelin receptor antagonist bosentan has been approved in several countries
for pulmonary arterial hypertension, and patients with portopulmonary hypertension (PPHTN) …

Assessment and prognostic relevance of right ventricular contractile reserve in patients with severe pulmonary hypertension

…, H Tiede, EO Enyimayew, N Ehlken, HJ Seyfarth… - Circulation, 2013 - Am Heart Assoc
Background— This study sought to analyze a new approach to assess exercise-induced
pulmonary artery systolic pressure (PASP) increase by means of stress Doppler …

Effects of nasal high flow on ventilation in volunteers, COPD and idiopathic pulmonary fibrosis patients

…, D Beyer, D Mai, S Hammerschmidt, HJ Seyfarth… - Respiration, 2013 - karger.com
Background: A high flow of air applied by large bore nasal cannulae has been suggested to
improve symptoms of chronic respiratory insufficiency. In pediatric patients, nasal high-flow (…